001     1006798
005     20231027114401.0
024 7 _ |a 10.1016/j.ymben.2023.04.001
|2 doi
024 7 _ |a 1096-7176
|2 ISSN
024 7 _ |a 1096-7184
|2 ISSN
024 7 _ |a 2128/34435
|2 Handle
024 7 _ |a 37031949
|2 pmid
024 7 _ |a WOS:001027176900001
|2 WOS
037 _ _ |a FZJ-2023-01851
082 _ _ |a 610
100 1 _ |a Schwanemann, Tobias
|0 P:(DE-Juel1)178720
|b 0
245 _ _ |a A Pseudomonas taiwanensis Malonyl-CoA platform strain for polyketide synthesis
260 _ _ |a Orlando, Fla.
|c 2023
|b Academic Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1684227716_22304
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Biotechnologie 1
520 _ _ |a Malonyl-CoA is a central precursor for biosynthesis of a wide range of complex secondary metabolites. The development of platform strains with increased malonyl-CoA supply can contribute to the efficient production of secondary metabolites, especially if such strains exhibit high tolerance towards these chemicals. In this study, Pseudomonas taiwanensis VLB120 was engineered for increased malonyl-CoA availability to produce bacterial and plant-derived polyketides. A multi-target metabolic engineering strategy focusing on decreasing the malonyl-CoA drain and increasing malonyl-CoA precursor availability, led to an increased production of various malonyl-CoA-derived products, including pinosylvin, resveratrol and flaviolin. The production of flaviolin, a molecule deriving from five malonyl-CoA molecules, was doubled compared to the parental strain by this malonyl-CoA increasing strategy. Additionally, the engineered platform strain enabled production of up to 84 mg L−1 resveratrol from supplemented p-coumarate. One key finding of this study was that acetyl-CoA carboxylase overexpression majorly contributed to an increased malonyl-CoA availability for polyketide production in dependence on the used strain-background and whether downstream fatty acid synthesis was impaired, reflecting its complexity in metabolism. Hence, malonyl-CoA availability is primarily determined by competition of the production pathway with downstream fatty acid synthesis, while supply reactions are of secondary importance for compounds that derive directly from malonyl-CoA in Pseudomonas.
536 _ _ |a 2172 - Utilization of renewable carbon and energy sources and engineering of ecosystem functions (POF4-217)
|0 G:(DE-HGF)POF4-2172
|c POF4-217
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Otto, Maike
|0 P:(DE-Juel1)176853
|b 1
700 1 _ |a Wynands, Benedikt
|0 P:(DE-Juel1)176854
|b 2
|u fzj
700 1 _ |a Marienhagen, Jan
|0 P:(DE-Juel1)144031
|b 3
700 1 _ |a Wierckx, Nick
|0 P:(DE-Juel1)176653
|b 4
|e Corresponding author
773 _ _ |a 10.1016/j.ymben.2023.04.001
|g p. S1096717623000538
|0 PERI:(DE-600)1471017-1
|p 219-230
|t Metabolic engineering
|v 77
|y 2023
|x 1096-7176
856 4 _ |u https://juser.fz-juelich.de/record/1006798/files/Schwanemann%202023%20-%20malonyl-CoA%20chassis%20JuSER%20version%203.DOCX
|y OpenAccess
|z StatID:(DE-HGF)0510
909 C O |o oai:juser.fz-juelich.de:1006798
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)178720
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)176854
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)144031
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)176653
913 1 _ |a DE-HGF
|b Forschungsbereich Erde und Umwelt
|l Erde im Wandel – Unsere Zukunft nachhaltig gestalten
|1 G:(DE-HGF)POF4-210
|0 G:(DE-HGF)POF4-217
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-200
|4 G:(DE-HGF)POF
|v Für eine nachhaltige Bio-Ökonomie – von Ressourcen zu Produkten
|9 G:(DE-HGF)POF4-2172
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-16
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b METAB ENG : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b METAB ENG : 2022
|d 2023-10-21
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21